Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site
- PMID: 7918372
- DOI: 10.1021/bi00204a021
Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site
Abstract
A systematic effort was made to elucidate the mode of recognition at the inositol 1,4,5-trisphosphate-specific receptor. Eleven D-myo-inositol phosphates were synthesized and tested for Ca(2+)-mobilizing and receptor-binding activities, which included Ins(1,3,4,5,6)P5, Ins(1,2,5,6)P4, Ins(1,3,4,5)P4, Ins(1,3,4,6)P4, Ins(1,4,5,6)P4, Ins(3,4,5,6)P4, Ins(1,3,4)P4, Ins(1,4,5)P3, Ins(1,5,6)P3, Ins(1,4)P2, and Ins(4,5)P2. Of these, Ins(1,4,5)P3, Ins(1,3,4,6)P4, Ins(1,3,4,5)P4, Ins(1,4,5,6)P4, and Ins(4,5)P2 were able to elicit Ca2+ release from rat brain microsomes. Binding experiments suggest that the ability of these polyphosphates to effect Ca2+ mobilization arises from interactions with the Ins(1,4,5)P3-specific receptor. Accordingly, a model accounting for the ligand recognition is proposed. The Ins(1,4,5)P3-binding site is presumably composed of two domains. The anchoring domain binds the 4,5-bisphosphate 6-hydroxy motif. Disruption of this structural feature abolishes the agonist activity. The auxiliary domain exerts long-range interactions with the 1-phosphate, thus enhancing the binding affinity. The stereochemical requirement for this electrostatic interaction is, however, less stringent. Evidence suggests that Ca(2+)-mobilizing inositol phosphates are able to effect productive binding by assuming conformations displaying or mimicking these essential structural features.
Similar articles
-
Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.Mol Pharmacol. 1996 Nov;50(5):1223-30. Mol Pharmacol. 1996. PMID: 8913354
-
Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.J Biol Chem. 1994 Oct 28;269(43):26815-21. J Biol Chem. 1994. PMID: 7929418
-
Synthesis and application of photoaffinity analogues of inositol 1,4,5-trisphosphate selectively substituted at the 1-phosphate group.Biochem J. 1990 Dec 15;272(3):817-25. doi: 10.1042/bj2720817. Biochem J. 1990. PMID: 2176480 Free PMC article.
-
Inositol polyphosphates and intracellular calcium release.Arch Biochem Biophys. 1989 Aug 15;273(1):1-15. doi: 10.1016/0003-9861(89)90156-2. Arch Biochem Biophys. 1989. PMID: 2667466 Review.
-
Control of glomerulosa cell function by angiotensin II: transduction by G-proteins and inositol polyphosphates.Clin Exp Pharmacol Physiol. 1988 Jul;15(7):501-15. doi: 10.1111/j.1440-1681.1988.tb01108.x. Clin Exp Pharmacol Physiol. 1988. PMID: 3152162 Review.
Cited by
-
Selective recognition of inositol phosphates by subtypes of the inositol trisphosphate receptor.Biochem J. 2001 Apr 1;355(Pt 1):59-69. doi: 10.1042/0264-6021:3550059. Biochem J. 2001. PMID: 11256949 Free PMC article.
-
Preparation and characterization of a D-myo-inositol 1,4,5-trisphosphate-specific antibody.Biochem J. 1995 Nov 1;311 ( Pt 3)(Pt 3):1009-14. doi: 10.1042/bj3111009. Biochem J. 1995. PMID: 7487917 Free PMC article.
-
scyllo-inositol pentakisphosphate as an analogue of myo-inositol 1,3,4,5,6-pentakisphosphate: chemical synthesis, physicochemistry and biological applications.Chembiochem. 2006 Jul;7(7):1114-22. doi: 10.1002/cbic.200600037. Chembiochem. 2006. PMID: 16755629 Free PMC article.
-
Activation of IP(3) receptors by synthetic bisphosphate ligands.Chem Commun (Camb). 2009 Mar 14;(10):1204-6. doi: 10.1039/b819328b. Epub 2009 Feb 4. Chem Commun (Camb). 2009. PMID: 19240874 Free PMC article.
-
The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks.Biochem J. 2002 Sep 15;366(Pt 3):831-7. doi: 10.1042/BJ20020279. Biochem J. 2002. PMID: 12076251 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous